Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy and medication effects on the pattern visual evoked potential.

Andrew M Geller1, H Ken Hudnell, Bradley V Vaughn

  • 1Neurotoxicology Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. geller.andrew@epa.gov

Documenta Ophthalmologica. Advances in Ophthalmology
|October 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rett syndrome: a review of clinical manifestations and therapeutic approaches.

Frontiers in sleep·2025
Same author

Assessing the effects of silver nanoparticles on ARPE-19 cells via high-throughput phenotypic profiling with the Cell Painting assay.

Toxicology and applied pharmacology·2025
Same author

U. S. federal perspective on critical research issues in nanoEHS.

Environmental science. Nano·2025
Same author

Sleep and Cancer.

Cancers·2025
Same author

Mining, refining, and QSAR analysing the nanoinformatics in EPA NaKnowBase.

Environmental science. Nano·2024
Same author

Community-level exposomics: a population-centered approach to address public health concerns.

Exposome·2024

Epilepsy and its medications impact visual function, affecting the visual evoked response (VEP). Generalized epilepsy shifts VEPs to lower spatial frequencies, while valproate medication reduces specific VEP components, suggesting GABAergic system involvement.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Pharmacology

Background:

  • Visual disturbances are common in epilepsy, potentially linked to the disease or anti-epileptic drugs (AEDs).
  • The GABAergic neurotransmitter system is implicated due to its role in epilepsy and visual processing.
  • AEDs like valproate modulate GABA levels, influencing neural circuitry in the visual cortex and retina.

Purpose of the Study:

  • To investigate the effects of epilepsy and AEDs on visual evoked potentials (VEP) using patterned stimuli.
  • To compare VEP responses between epilepsy types (generalized vs. complex partial) and control groups.
  • To assess the impact of specific AEDs (valproate vs. carbamazepine) on VEP characteristics.

Main Methods:

  • Measured steady-state visual evoked potentials (VEP) using onset-offset modulated sine-wave stimuli.

Related Experiment Videos

  • Analyzed VEP spectral amplitude as a function of spatial frequency in 24 controls and 54 epileptic patients.
  • Compared VEPs between generalized epilepsy, complex partial epilepsy, and control groups, and analyzed effects of valproate and carbamazepine.

    • Main Results:

    • The fundamental (F1) VEP component amplitude differed significantly between epilepsy types.
    • Generalized epilepsy patients showed VEP F1 peaks shifted to lower spatial frequencies compared to controls and complex partial epilepsy patients.
    • The second harmonic (F2) VEP response was sensitive to medication, with valproate (VPA) reducing F2 amplitude, consistent with GABAergic effects.

    Conclusions:

    • Epilepsy type influences VEPs, with generalized epilepsy potentially indicating reduced intracortical inhibition.
    • AEDs, particularly valproate, affect VEPs, highlighting the role of GABAergic pathways in visual processing alterations.
    • VEP analysis provides insights into visual system dysfunction in epilepsy and the impact of specific medications.